These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 16093228
1. Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. Paviour DC, Winterburn D, Simmonds S, Burgess G, Wilkinson L, Fox NC, Lees AJ, Jahanshahi M. Neurocase; 2005 Aug; 11(4):274-82. PubMed ID: 16093228 [Abstract] [Full Text] [Related]
2. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy. Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R. J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897 [Abstract] [Full Text] [Related]
3. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias. Stamelou M, Diehl-Schmid J, Hapfelmeier A, Kontaxopoulou D, Stefanis L, Oertel WH, Bhatia KP, Papageorgiou SG, Höglinger GU. Parkinsonism Relat Disord; 2015 Oct; 21(10):1264-8. PubMed ID: 26324212 [Abstract] [Full Text] [Related]
4. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy. Sitek EJ, Konkel A, Dąbrowska M, Sławek J. Neurol Neurochir Pol; 2015 Oct; 49(1):36-40. PubMed ID: 25666771 [Abstract] [Full Text] [Related]
5. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M. J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175 [Abstract] [Full Text] [Related]
6. Differentiation of parkinsonian syndromes according to differences in executive functions. Lange KW, Tucha O, Alders GL, Preier M, Csoti I, Merz B, Mark G, Herting B, Fornadi F, Reichmann H, Vieregge P, Reiners K, Becker G, Naumann M. J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023 [Abstract] [Full Text] [Related]
7. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease. Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R. J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258 [Abstract] [Full Text] [Related]
8. Attention and cognition in bradykinetic-rigid syndromes: an event-related potential study. Pirtosek Z, Jahanshahi M, Barrett G, Lees AJ. Ann Neurol; 2001 Nov; 50(5):567-73. PubMed ID: 11706961 [Abstract] [Full Text] [Related]
9. Clinical Profile of Cognitive Decline in Patients with Parkinson's Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy. Sulena, Gupta D, Sharma AK, Kumar N. J Neurosci Rural Pract; 2017 Nov; 8(4):562-568. PubMed ID: 29204015 [Abstract] [Full Text] [Related]
10. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism. Leiguarda RC, Pramstaller PP, Merello M, Starkstein S, Lees AJ, Marsden CD. Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799 [Abstract] [Full Text] [Related]
11. Cognitive profiling in relation to short latency afferent inhibition of frontal cortex in multiple system atrophy. Celebi O, Temuçin ÇM, Elibol B, Saka E. Parkinsonism Relat Disord; 2014 Jun; 20(6):632-6. PubMed ID: 24698055 [Abstract] [Full Text] [Related]
12. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease. Somme J, Gómez-Esteban JC, Tijero B, Berganzo K, Lezcano E, Zarranz JJ. Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819 [Abstract] [Full Text] [Related]
13. Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease. Krishnan S, Mathuranath PS, Sarma S, Kishore A. Neurol India; 2006 Sep; 54(3):268-72. PubMed ID: 16936386 [Abstract] [Full Text] [Related]
14. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Neurocase; 2005 Aug; 11(4):268-73. PubMed ID: 16093227 [Abstract] [Full Text] [Related]
15. Executive dysfunction, behavioral changes and quality of life in Chinese patients with progressive supranuclear palsy. Ou R, Liu H, Hou Y, Wei Q, Cao B, Zhao B, Shang H. J Neurol Sci; 2017 Sep 15; 380():182-186. PubMed ID: 28870563 [Abstract] [Full Text] [Related]
16. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Rusz J, Bonnet C, Klempíř J, Tykalová T, Baborová E, Novotný M, Rulseh A, Růžička E. J Neurol; 2015 Sep 15; 262(4):992-1001. PubMed ID: 25683763 [Abstract] [Full Text] [Related]
17. Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy. Luca A, Nicoletti A, Donzuso G, Terravecchia C, Cicero CE, D'Agate C, Rascuná C, Manna R, Mostile G, Zappia M. J Alzheimers Dis; 2021 Sep 15; 80(4):1669-1674. PubMed ID: 33720901 [Abstract] [Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy. Paviour DC, Thornton JS, Lees AJ, Jäger HR. Mov Disord; 2007 Jan 15; 22(1):68-74. PubMed ID: 17089396 [Abstract] [Full Text] [Related]
20. The validity and reliability of chinese frontal assessment battery in evaluating executive dysfunction among Chinese patients with small subcortical infarct. Mok VC, Wong A, Yim P, Fu M, Lam WW, Hui AC, Yau C, Wong KS. Alzheimer Dis Assoc Disord; 2004 Jul 15; 18(2):68-74. PubMed ID: 15249850 [Abstract] [Full Text] [Related] Page: [Next] [New Search]